Recent News

By Category: Agents & Toxins

Pharmathene Announces Publication of Phase I Study Results for Anthrax Antibody

(Sacramento Bee) The American Society for Microbiology peer-reviewed journal describes clinical data supporting the potential use of Valortim ® , a fully human monoclonal antibody, as both a post-exposure prophylaxis and therapeutic treatment for anthrax infection. …

Defensive measures: Toward a vaccine for Ebola

(Arizona State University) Charles Arntzen, a researcher at the Biodesign Institute at Arizona State University, along with colleagues from ASU, the University of Arizona College of Medicine-Phoenix, and the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, have made progress toward a vaccine against the deadly Ebola virus.

Namibia: Foot-And-Mouth Hits Caprivi

(AllAfrica.com) Katima Mulilo — The movement of cattle, milk and produce such as grass in and outside Caprivi Region has been suspended following the outbreak of foot-and-mouth disease (FMD) at Masikili, some 75 kilometres east of Katima Mulilo in Kabbe constituency. According to regional state veterinarian Dr Frank Chitate, about 37 cattle out of 67  Read More »

Ricin: Scientists deal a blow to terrorism as they close in on antidote …

(Daily Mail) An antidote to ricin – one of the world’s deadliest poisons – could be developed after scientists discovered a key gene which provides immunity. Ricin has been used in bioweapons by terrorist groups such as al Qaeda and was used to kill Bulgarian dissident Georgi Markov, who was stabbed in the ankle with  Read More »

Engineered botulism toxins could have broader role in medicine

(e! Science News) The most poisonous substance on Earth — already used medically in small doses to treat certain nerve disorders and facial wrinkles — could be re-engineered for an expanded role in helping millions of people with rheumatoid arthritis, asthma, psoriasis and other diseases, scientists are reporting. Their study appears in ACS’ journal Biochemistry.  Read More »